Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

4.150 -0.030 (-0.72%)

Streaming Delayed Price Updated: 9:47 AM EDT, Aug 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	151,525
Open	4.370
Bid (Size)	4.150 (500)
Ask (Size)	4.170 (1,600)
Prev. Close	4.180
Today's Range	4.110 - 4.400
52wk Range	3.280 - 6.180
Shares Outstanding	136,360,208
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Cytek Biosciences Q2 Earnings Call Highlights ↗

August 05, 2026

Cytek Biosciences (NASDAQ:CTKB) reported second-quarter 2026 revenue growth of 6% year over year, supported by double-digit gains in the United States and China, while continued weakness in Europe and...

Via MarketBeat

Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement

July 15, 2026

From Cytek Biosciences, Inc.

Via GlobeNewswire

Performance

YTD	-15.7%	-15.7%
1 Month	-10.2%	-10.2%
3 Month	-16.0%	-16.0%
6 Month	-15.8%	-15.8%
1 Year	+7.0%	+7.0%

More News

Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference

June 10, 2026

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026

June 02, 2026

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings ↗

February 26, 2026

Via Chartmill

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech

May 13, 2026

From USA News Group

Via GlobeNewswire

Cytek (CTKB) Q1 2026 Earnings Call Transcript ↗

May 08, 2026

Via The Motley Fool

Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact

March 09, 2026

From Cytek Biosciences, Inc.

Via GlobeNewswire

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock ↗

May 28, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Cytek (CTKB) Q4 2025 Earnings Call Transcript ↗

February 27, 2026

Via The Motley Fool

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday ↗

November 14, 2025

Via Benzinga

TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026

November 12, 2025

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year

November 06, 2025

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek (CTKB) Q3 2025 Earnings Call Transcript ↗

November 05, 2025

Via The Motley Fool

Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry

October 29, 2025

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth

October 15, 2025

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA

September 10, 2025

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

May 29, 2025

From Cytek Biosciences, Inc.

Via GlobeNewswire

DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

May 28, 2025

Via Benzinga

Cytek Biosciences Reports First Quarter 2025 Financial Results

May 08, 2025

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

April 29, 2025

From Cytek Biosciences, Inc.

Via GlobeNewswire

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

March 18, 2025

From Cytek Biosciences, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Cytek Biosciences, Inc. - Common Stock publicly traded?

Yes, Cytek Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Cytek Biosciences, Inc. - Common Stock trade on?

Cytek Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Cytek Biosciences, Inc. - Common Stock?

The ticker symbol for Cytek Biosciences, Inc. - Common Stock is CTKB on the Nasdaq Stock Market

What is the current price of Cytek Biosciences, Inc. - Common Stock?

The current price of Cytek Biosciences, Inc. - Common Stock is 4.150

When was Cytek Biosciences, Inc. - Common Stock last traded?

The last trade of Cytek Biosciences, Inc. - Common Stock was at 08/06/26 09:47 AM ET

What is the market capitalization of Cytek Biosciences, Inc. - Common Stock?

The market capitalization of Cytek Biosciences, Inc. - Common Stock is 565.89M

How many shares of Cytek Biosciences, Inc. - Common Stock are outstanding?

Cytek Biosciences, Inc. - Common Stock has 566M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.